Posted : 2020-12-23 16:57
By Anna J. Park
Microbiome- focused biopharmaceutical firm Genome & Company made its first-day debut on the nation s heavy-tech KOSDAQ market Wednesday, transferring its listing from the KONEX market ― the bourse market for venture startups and small- and medium-sized enterprises ― where its stocks had been traded since December 2018.
Since its listing at KONEX two years ago, Genome & Company grew to be the market s top company in terms of market cap, with about 741 billion won as of the end of November. With Wednesday s transfer listing to KOSDAQ, the biopharmaceutical company s market capitalization grew to 912 billion won.
The company s stock price began at 80,000 won ― double the price of its 40,000 won subscription price ― at the beginning of Wednesday s trading session, and the price soon went up to 95,000 won in just 15 minutes after the market opened at 9 a.m. Yet the price continued to drop, despite fluctuations in between, finishing at